On February 16, 2023, Food Standards Australia New Zealand (FSANZ) announced the approval of Application A1253, allowing the voluntary addition of bovine lactoferrin as a nutritive substance in infant formula products. Considering the nutrition’s necessity in the products and relevant international regulations, the maximum usage level of bovine lactoferrin is 40 mg/100 kJ.
This application was submitted by Synlait Milk Ltd. (hereinafter “Synlait”). According to the approval report, Synlait has an exclusive usage period of 15 months for bovine lactoferrin after gazettal, that is, only bovine lactoferrin under the brand Synlait may be used as a nutritive substance in infant formula products.
Lactoferrin, an iron-binding protein that naturally exists in human body, is present in mammalian milks and notably at high levels in human milk. It possesses potent antibacterial activity against a variety of bacteria, fungi, yeasts, viruses and parasites. The purpose of adding bovine lactoferrin is to make the composition of infant formula products closer to that of breast milk, and reduce the risk of infection in formula-fed infants.
We provide full-scale global food market entry services (including product registration, ingredient review, regulatory consultation, customized training, market research, branding strategy). Please contact us to discuss how we can help you by 
